Ridding Redness

Article

San Francisco - Monotherapy with tacrolimus 0.1 percent ointment (Protopic) is an effective and generally well-tolerated treatment for moderate to severe chronic red face, Wayne H. Fujita, M.D., said at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023
© 2023 MJH Life Sciences

All rights reserved.